Akèy › Kolit Ulseratif › Kansas
Etid klinik pou Kolit Ulseratif nan Kansas
10 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 006, Kansas City
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- University of Kansas Medical Center ( Site 1077), Kansas City
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Cotton O'Neil Digestive Health Center, Topeka
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- ak 7 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 21, 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kansas Medical Center - Site Number: 8400110, Kansas City
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Kansas Gastro, Wichita
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.